RVNC logo

Revance Therapeutics (RVNC) Price To Book Ratio

PB Ratio

-2.35
0.000.00%

Thu, 06 Feb 2025 21:00:00 GMT


Summary


Performance

RVNC PB Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherRVNCvaluationmetrics:

PB Ratio Formula

P/B =  
Price
Quarterly Book Value

RVNC PB Ratio Trends

PeriodPeriodPB ratioPB ratioPricePriceMarket capMarket capPE ratioPE ratio
todaytoday0.0%0.0%0.0%-
1 m1 month-6.8%+6.8%+6.8%-
3 m3 months+25.2%-25.2%-25.2%-
6 m6 months+2.9%+22.1%+22.2%-
ytdytd-19.3%+19.3%+19.3%-
1 y1 year+28.4%-35.4%-23.0%-
5 y5 years-135.0%-86.3%-74.7%-

RVNC PB Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-11.9%-2.37+0.8%
3 m3-month-1.94-21.1%-3.64+35.4%
6 m6-month-1.94-21.1%-5.31+55.7%
1 y1-year-1.94-21.1%-5.43+56.7%
3 y3-year235.39-101.0%-850.90+99.7%
5 y5-year235.39-101.0%-850.90+99.7%
alltimeall time235.39-101.0%-850.90+99.7%

Revance Therapeutics PB Ratio History

DateValue
2025
-2.35(+19.3%)
2024
-1.97(-62.1%)
2023
-5.20(-104.3%)
2022
121.94(+614.8%)
2021
17.06(+225.6%)
2020
5.24(+39.0%)
DateValue
2019
3.77(-26.2%)
2018
5.11(+5.1%)
2017
4.86(+45.1%)
2016
3.35(-12.3%)
2015
3.82(+67.5%)
2014
2.28

FAQ

  • What is Revance Therapeutics price to book ratio?
  • What is the all time high PB ratio for Revance Therapeutics?
  • What is RVNC price to book ratio year-to-date change?
  • What is Revance Therapeutics PB ratio year-on-year change?

What is Revance Therapeutics price to book ratio?

The current PB ratio of RVNC is -2.35

What is the all time high PB ratio for Revance Therapeutics?

Revance Therapeutics all-time high price to book ratio is 235.39

What is RVNC price to book ratio year-to-date change?

Revance Therapeutics price to book ratio has changed by -0.38 (-19.29%) since the beginning of the year

What is Revance Therapeutics PB ratio year-on-year change?

Over the past year, RVNC price to book ratio has changed by +0.93 (+28.35%)